News Quantified

LCTX – lineage cell therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering [Yahoo! Finance]

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

-2.3%

BEAT

2.5%

BEAT

-0.8%

IN-LINE

15.0%

BEAT

Top News Gainers

12/24 Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets 25.2%

2/10 Lineage Cell Therapeutics to Present at NobleCon16 - Noble Capital Markets' Sixteenth Annual Investor Conference 18.5%

12/30 Lineage Provides Update on Patient Enrollment in Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration 14.3%

2/6 Lineage Provides Positive Update on Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration 13.9%

4/29 Lineage Cell Therapeutics to Report First Quarter 2020 Financial Results and Provide Business Update on May 7, 2020 12.7%

3/17 Lineage Cell Therapeutics, Inc. (NASDAQ: LCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. 9.8%

11/15 Lineage Cell Therapeutics Provides Update on SCiStar Clinical Study and OPC1 Spinal Cord Injury Program 9.4%

8/13 Lineage Cell Therapeutics Awarded NIH Grant for Innovative Vision Restoration Program 7.4%

3/12 Q4/2019 12/31/2019 EPS -0.030 ZacksConsensus -0.070 ActVsEst 0.040 - Beat 7.2%

11/5 Lineage Cell Therapeutics to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019 4.9%

Top News Decliners

8/26 Lineage Cell Therapeutics Announces Issuance of U.S. Patent for System for Generating Immunogenic Dendritic Cells -11.0%

8/12 Lineage Cell Therapeutics Launches New Corporate Brand -9.2%

9/26 Lineage Cell Therapeutics to Present at 2019 Cantor Global Healthcare Conference on October 4, 2019 -9.1%

12/10 Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells -6.7%

12/19 Lineage Cell Therapeutics Provides Shareholder Update -4.8%

3/5 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Business Update on March 12, 2020 -4.1%

9/23 Lineage Cell Therapeutics to Present at 2019 Cell & Gene Meeting on the Mesa on October 3, 2019 -3.7%

10/14 Lineage Cell Therapeutics Presents New OpRegen® Data at American Academy of Ophthalmology Annual Meeting -3.0%

9/4 Lineage Cell Therapeutics Announces Issuance of U.S. Patent for Method of Treating Spinal Cord Injury With Stem Cell-Derived Oligodendrocyte Progenitor Cells -2.2%

9/10 Lineage Cell Therapeutics (LCTX ) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow [Seeking Alpha] -1.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day